Intracellular metabolism of β-L-2',3'-dideoxyadenosine: Relevance to its limited antiviral activity

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 4, 2000, Pages 853-858

  Placidi, Laurent ^a   Cretton Scott, Erika ^a   Gosselin, Gilles ^b   Pierra, Claire ^b   Schinazi, Raymond F ^c   Imbach, Jean Louis ^b   El Kouni, Mahmoud H ^a   Sommadossi, Jean Pierre ^a  

^a University of Alabama at Birmingham ^*  (United States)

^b UNIV MONTPELLIER   (France)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYADENOSINE; 5' METHYLTHIOADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; HYPOXANTHINE DERIVATIVE; INOSINE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL METABOLISM; DOSE TIME EFFECT RELATION; DRUG METABOLISM; ENANTIOMER; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS REPLICATION;

ADENOSINE; ANTIVIRAL AGENTS; CELL LINE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYOPRESERVATION; DIDEOXYADENOSINE; HEPATITIS B VIRUS; HIV; HUMANS; LIVER; MONOCYTES; THIONUCLEOSIDES;

EID: 0034075745     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.4.853-858.2000     Document Type: Article

References (15)

1. Bolon, P. J., P. Wang, C. K. Chu, G. Gosselin, V. Boudou, J. L. Imbach, A. M. Aubertin, A. Faraj, A. M. El Alaoui, J. P. Sommadossi, S. B. Pai, Y. L. Zhu, Y. C. Cheng, and R. F. Schinazi. 1996. Anti-HIV and anti-hepatitis B virus activities of L-d2A, L-d4A and their analogs. Bioorg. Med. Chem. Lett. 6:1657-1662.
2. Chu, C. K., T. Ma, K. Shammuganathan, C. Wang, C. Xiang, S. B. Pai, G. Q. Yao, J. P. Sommadossi, and Y. C. Cheng. 1995. Use of 2′-fluoro-5-β-L-arabinofuranosyl uracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob. Agents Chemother. 39:979-981.
3. Dienstag, J. L., R. P. Perillo, E. R. Schiff, M. Bartholomew, C. Vicary, and M. Rubin. 1995. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333:1657-1661.
4. El Alaoui, A. M., A. Faraj, C. Pierra, V. Boudou, R. Johnson, C. Mathe, G. Gosselin, B. E. Korba, J. L. Imbach, R. F. Schinazi, and J. P. Sommadossi. 1996. Inhibition of hepatitis B virus replication by nucleoside enantiomers of β-2′,3′-dideoxypurine analogues. Antivir. Chem. Chemother. 7:276-280.
5. Furman, P. A., M. Davis, D. C. Liotta, M. Paff, L. W. Frick, D. J. Nelson, R. E. Dornsife, J. A. Wurster, L. J. Wilson, J. A. Fyfe, J. V. Tuttle, W. H. Miller, L. Condreay, D. R. Averett, R. F. Schinazi, and G. R. Painter. 1992. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36:2686-2692.
6. Gosselin, G., V. Boudou, J. F. Griffon, G. Pavia, C. Pierra, J. L. Imbach, A. M. Aubertin, R. F. Schinazi, and J. P. Sommadossi. 1997. New unnatural L-nucleoside enantiomers: from their stereospecific synthesis to their biological activities. Nucleosides Nucleotides 16:1389-1398.
7. Johnson, M. A., and A. Fridland. 1989. Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells. Mol. Pharmacol. 36:291-295.
8. Lin, T. S., M. Z. Luo, J. L. Zhu, M. C. Liu, Y. L. Zhu, G. E. Dutschman, and Y. C. Cheng. 1995. Synthesis of a series of purine 2′,3′-dideoxy-L-nucleoside analogues as potential antiviral agents. Nucleosides Nucleotides 14:1759-1783.
9. Lin, T. S., M. Z. Luo, M. C. Liu, M. C. Zhu, Y. L. Zhu, E. Gullen, G. E. Dutschman, and Y. C. Cheng. 1996. Design and synthesis of 2′,3′-dideoxy-2′,3′-didehydro-β-L-cytidine (β-L-d4C) and 2′,3′-dideoxy-2′,3′-didehydro-β-L-5-fluorocytidine (β-L-F-d4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro. J. Med. Chem. 39:1757-1759.
10. Pelicano, H., C. Pierra, S. Eriksson, G. Gosselin, J. L. Imbach, and G. Maury. 1997. Enzymatic properties of the unnatural β-L-enantiomers of 2′,3′-dideoxyadenosine and 2′,3′-didehydro-2′,3′-dideoxyadenosine. J. Med. Chem. 40:3969-3973.
11. Porter, C. W., and J. R. Sufrin. 1986. Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy. Anticancer Res. 6:525-542.
12. Schinazi, R. F., A. McMillan, D. Cannon, R. Mathis, R. M. Lloyd, A. Peck, J. P. Sommadossi, M. St Clair, J. Wilson, P. A. Furman, G. Painter, W. B. Chol, and D. C. Liotta. 1992. Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 36:2423-2431.
13. Schinazi, R. F., G. Gosselin, A. Faraj, B. Korba, D. Liotta, C. K. Chu, C. Mathe, J. L. Imbach, and J. P. Sommadossi. 1994. Pure nucleoside enantiomers of β-2′,3′-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro. Antimicrob. Agents Chemother. 38:2172-2174.
14. Tisdale, M. J. 1983. Methionine synthesis from 5′-methylthioadenosine by tumour cells. Biochem. Pharmacol. 32:2915-2920.
15. Wang, P., J. H. Hong, J. S. Cooperwood, and C. K. Chu. 1998. Recent advances in L-nucleosides: chemistry and biology. Antivir. Res. 40:19-44.